Budapest Upgrade CRT


Pharmahungary Group, as clinical R&D service provider is coordinating an international Investigator Initiated Trial in cardio intervention indication with CRT-D medical device.

As the CRO of the Budapest Upgrade CRT trial Pharmahungary is responsible for all European sites including CA/CEC submission and site management during the course of the trial.

The trial is currently recruiting in 5 countries with 10 sites. For more information: